ArticleKardiologia polska2008
[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].
Marcin DominiakPubMed ↗
No numbers read from the abstract.
4 papers cite it
this papercites it